Header banner
Revain logoHome Page
Barbara Scholz photo
1 Level
5 Review
5 Karma

Review on ICON by Barbara Scholz

Revainrating 4 out of 5

The partnerships with financial, insurance, and medical consortiums…

The partnerships with financial, insurance, and medical consortiums demonstrates that major companies see the merit of the systems already offered. Alone the example of the insurance consortium having the ability to securely receive the medical data of their customers and review the case in less time than the previous system allowed, is an important use case, and when scaled across all sectors that ICON is working in, as well as when combined with other elements such as Chain ID, the DEX, and various DApps that will launch over time, we can see the potential for an intricate ecosystem to develop.



Pros
  • An inherent barrier for ICX is simply that it is a platform, and has plenty of competition to contend with – Ethereum, Bancor, EOS, HPB, and more – they all want a slice of the pie. However, this doesn’t mean they don’t have the ability to pull it off. The team itself appears more than capable, with backing by Dayli Financial, Dayli Intelligence, and the strong blockchain background of theloop team giving us confidence that they will be able to pull off the technical aspect of the project
Cons
  • With ICOs being launchable via the ICON platform we should also see an uptick in what services are running on the platform, as well as demand for the token over time; both ETH and NEO saw huge increases in demand as their own prominent ICOs were launched, and we expect the same to be the case for ICON.

Similar reviews